Global Bovine-based Collagen for Biomedical Applications Market

Bovine-based Collagen for Biomedical Applications Comprehensive Study by Application (Bone Graft Substitutes, Collagen-based Scaffolds, Hemostats, Skin Substitutes, Cartilage Repairs, Others), Major constituent (Type-I Collagen, Type-III Collagen), Dosage forms (Bovine Gelatin, Hydrolyzed Bovine Collagen, Others(Powder, Granule Agent )), Source (Cartilage, Bones, Hides of Cows, Others) Players and Region - Global Market Outlook to 2026

Bovine-based Collagen for Biomedical Applications Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Bovine-based Collagen for Biomedical Applications Market Scope?
Bovine collagen is a protein found naturally in cow connective tissue, bones, cartilage, and hides. Collagen supplements in stores are typically derived from cowhides. Collagen comes in a variety of forms, each with its own set of amino acids. Cow collagen is structurally similar to collagen found in our own bodies. There are three types of collagen: Type I, Type II, and Type III, which comprise about 90% of all the collagen in the human body, and bovine collagen supplements typically contain Type I and Type III. According to the FDA, bovine collagen is just as safe as collagen from other sources. Bovine collagen is less expensive and more widely available on the market. As a result, many people who are concerned about their health and appearance prefer bovine collagen. It is also an excellent choice for those who are allergic to shellfish and cannot consume marine collagen.

The Bovine-based Collagen for Biomedical Applications market study is being classified, by Application (Bone Graft Substitutes, Collagen-based Scaffolds, Hemostats, Skin Substitutes, Cartilage Repairs and Others) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Bovine-based Collagen for Biomedical Applications market throughout the predicted period.

BBI Solutions (United Kingdom), Symatese (France), Gurnet Point Capital(United States), Collagen Solutions LLP(United Kingdom), Botiss biomaterials GmbH (Germany), Medtronic (Ireland), Taxus Cardium (United States), KYERON (India), Collagen Matrix, Inc (United States) and FOODMATE CO., LTD. (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Weishardt (France), Nitta Gelatin Inc.(Japan) and LAPI GELATINE S.p.a.(Italy).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Bovine-based Collagen for Biomedical Applications market by Type, Application and Region.

On the basis of geography, the market of Bovine-based Collagen for Biomedical Applications has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Ongoing r&d for the development of wound healing & regenerative medicines

Market Drivers
  • Increasing demand for bovine-based collagen in biomedical applications to treat various medical conditions like arthritis, osteoporosis, and improving skin health.

Opportunities
  • The aging of populations worldwide will be responsible for a major increase in the incidence of osteoporosis in postmenopausal women and indirectly boosting the market growth.
  • Growth in interest and demand for collagen-based products that are obtained through various animal sources

Restraints
  • The high risk of disease transmission

Challenges
  • Lack of knowledge regarding the benefits of the bovine Collagen


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Bovine-based Collagen for Biomedical Applications Providers, Government Regulatory and Research Organizations and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Application
  • Bone Graft Substitutes
  • Collagen-based Scaffolds
  • Hemostats
  • Skin Substitutes
  • Cartilage Repairs
  • Others
By Major constituent
  • Type-I Collagen
  • Type-III Collagen

By Dosage forms
  • Bovine Gelatin
  • Hydrolyzed Bovine Collagen
  • Others(Powder, Granule Agent )

By Source
  • Cartilage
  • Bones
  • Hides of Cows
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing demand for bovine-based collagen in biomedical applications to treat various medical conditions like arthritis, osteoporosis, and improving skin health.
    • 3.3. Market Challenges
      • 3.3.1. Lack of knowledge regarding the benefits of the bovine Collagen
    • 3.4. Market Trends
      • 3.4.1. Ongoing r&d for the development of wound healing & regenerative medicines
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bovine-based Collagen for Biomedical Applications, by Application, Major constituent, Dosage forms, Source and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Bovine-based Collagen for Biomedical Applications (Value)
      • 5.2.1. Global Bovine-based Collagen for Biomedical Applications by: Application (Value)
        • 5.2.1.1. Bone Graft Substitutes
        • 5.2.1.2. Collagen-based Scaffolds
        • 5.2.1.3. Hemostats
        • 5.2.1.4. Skin Substitutes
        • 5.2.1.5. Cartilage Repairs
        • 5.2.1.6. Others
      • 5.2.2. Global Bovine-based Collagen for Biomedical Applications by: Major constituent (Value)
        • 5.2.2.1. Type-I Collagen
        • 5.2.2.2. Type-III Collagen
      • 5.2.3. Global Bovine-based Collagen for Biomedical Applications by: Dosage forms (Value)
        • 5.2.3.1. Bovine Gelatin
        • 5.2.3.2. Hydrolyzed Bovine Collagen
        • 5.2.3.3. Others(Powder, Granule Agent )
      • 5.2.4. Global Bovine-based Collagen for Biomedical Applications by: Source (Value)
        • 5.2.4.1. Cartilage
        • 5.2.4.2. Bones
        • 5.2.4.3. Hides of Cows
        • 5.2.4.4. Others
      • 5.2.5. Global Bovine-based Collagen for Biomedical Applications Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Bovine-based Collagen for Biomedical Applications (Volume)
      • 5.3.1. Global Bovine-based Collagen for Biomedical Applications by: Application (Volume)
        • 5.3.1.1. Bone Graft Substitutes
        • 5.3.1.2. Collagen-based Scaffolds
        • 5.3.1.3. Hemostats
        • 5.3.1.4. Skin Substitutes
        • 5.3.1.5. Cartilage Repairs
        • 5.3.1.6. Others
      • 5.3.2. Global Bovine-based Collagen for Biomedical Applications by: Major constituent (Volume)
        • 5.3.2.1. Type-I Collagen
        • 5.3.2.2. Type-III Collagen
      • 5.3.3. Global Bovine-based Collagen for Biomedical Applications by: Dosage forms (Volume)
        • 5.3.3.1. Bovine Gelatin
        • 5.3.3.2. Hydrolyzed Bovine Collagen
        • 5.3.3.3. Others(Powder, Granule Agent )
      • 5.3.4. Global Bovine-based Collagen for Biomedical Applications by: Source (Volume)
        • 5.3.4.1. Cartilage
        • 5.3.4.2. Bones
        • 5.3.4.3. Hides of Cows
        • 5.3.4.4. Others
      • 5.3.5. Global Bovine-based Collagen for Biomedical Applications Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Bovine-based Collagen for Biomedical Applications (Price)
  • 6. Bovine-based Collagen for Biomedical Applications: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BBI Solutions (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Symatese (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Gurnet Point Capital(United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Collagen Solutions LLP(United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Botiss biomaterials GmbH (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medtronic (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Taxus Cardium (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. KYERON (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Collagen Matrix, Inc (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. FOODMATE CO., LTD. (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Bovine-based Collagen for Biomedical Applications Sale, by Application, Major constituent, Dosage forms, Source and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Bovine-based Collagen for Biomedical Applications (Value)
      • 7.2.1. Global Bovine-based Collagen for Biomedical Applications by: Application (Value)
        • 7.2.1.1. Bone Graft Substitutes
        • 7.2.1.2. Collagen-based Scaffolds
        • 7.2.1.3. Hemostats
        • 7.2.1.4. Skin Substitutes
        • 7.2.1.5. Cartilage Repairs
        • 7.2.1.6. Others
      • 7.2.2. Global Bovine-based Collagen for Biomedical Applications by: Major constituent (Value)
        • 7.2.2.1. Type-I Collagen
        • 7.2.2.2. Type-III Collagen
      • 7.2.3. Global Bovine-based Collagen for Biomedical Applications by: Dosage forms (Value)
        • 7.2.3.1. Bovine Gelatin
        • 7.2.3.2. Hydrolyzed Bovine Collagen
        • 7.2.3.3. Others(Powder, Granule Agent )
      • 7.2.4. Global Bovine-based Collagen for Biomedical Applications by: Source (Value)
        • 7.2.4.1. Cartilage
        • 7.2.4.2. Bones
        • 7.2.4.3. Hides of Cows
        • 7.2.4.4. Others
      • 7.2.5. Global Bovine-based Collagen for Biomedical Applications Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Bovine-based Collagen for Biomedical Applications (Volume)
      • 7.3.1. Global Bovine-based Collagen for Biomedical Applications by: Application (Volume)
        • 7.3.1.1. Bone Graft Substitutes
        • 7.3.1.2. Collagen-based Scaffolds
        • 7.3.1.3. Hemostats
        • 7.3.1.4. Skin Substitutes
        • 7.3.1.5. Cartilage Repairs
        • 7.3.1.6. Others
      • 7.3.2. Global Bovine-based Collagen for Biomedical Applications by: Major constituent (Volume)
        • 7.3.2.1. Type-I Collagen
        • 7.3.2.2. Type-III Collagen
      • 7.3.3. Global Bovine-based Collagen for Biomedical Applications by: Dosage forms (Volume)
        • 7.3.3.1. Bovine Gelatin
        • 7.3.3.2. Hydrolyzed Bovine Collagen
        • 7.3.3.3. Others(Powder, Granule Agent )
      • 7.3.4. Global Bovine-based Collagen for Biomedical Applications by: Source (Volume)
        • 7.3.4.1. Cartilage
        • 7.3.4.2. Bones
        • 7.3.4.3. Hides of Cows
        • 7.3.4.4. Others
      • 7.3.5. Global Bovine-based Collagen for Biomedical Applications Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Bovine-based Collagen for Biomedical Applications (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bovine-based Collagen for Biomedical Applications: by Application(USD Million)
  • Table 2. Bovine-based Collagen for Biomedical Applications Bone Graft Substitutes , by Region USD Million (2015-2020)
  • Table 3. Bovine-based Collagen for Biomedical Applications Collagen-based Scaffolds , by Region USD Million (2015-2020)
  • Table 4. Bovine-based Collagen for Biomedical Applications Hemostats , by Region USD Million (2015-2020)
  • Table 5. Bovine-based Collagen for Biomedical Applications Skin Substitutes , by Region USD Million (2015-2020)
  • Table 6. Bovine-based Collagen for Biomedical Applications Cartilage Repairs , by Region USD Million (2015-2020)
  • Table 7. Bovine-based Collagen for Biomedical Applications Others , by Region USD Million (2015-2020)
  • Table 8. Bovine-based Collagen for Biomedical Applications: by Major constituent(USD Million)
  • Table 9. Bovine-based Collagen for Biomedical Applications Type-I Collagen , by Region USD Million (2015-2020)
  • Table 10. Bovine-based Collagen for Biomedical Applications Type-III Collagen , by Region USD Million (2015-2020)
  • Table 11. Bovine-based Collagen for Biomedical Applications: by Dosage forms(USD Million)
  • Table 12. Bovine-based Collagen for Biomedical Applications Bovine Gelatin , by Region USD Million (2015-2020)
  • Table 13. Bovine-based Collagen for Biomedical Applications Hydrolyzed Bovine Collagen , by Region USD Million (2015-2020)
  • Table 14. Bovine-based Collagen for Biomedical Applications Others(Powder, Granule Agent ) , by Region USD Million (2015-2020)
  • Table 15. Bovine-based Collagen for Biomedical Applications: by Source(USD Million)
  • Table 16. Bovine-based Collagen for Biomedical Applications Cartilage , by Region USD Million (2015-2020)
  • Table 17. Bovine-based Collagen for Biomedical Applications Bones , by Region USD Million (2015-2020)
  • Table 18. Bovine-based Collagen for Biomedical Applications Hides of Cows , by Region USD Million (2015-2020)
  • Table 19. Bovine-based Collagen for Biomedical Applications Others , by Region USD Million (2015-2020)
  • Table 20. South America Bovine-based Collagen for Biomedical Applications, by Country USD Million (2015-2020)
  • Table 21. South America Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 22. South America Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 23. South America Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 24. South America Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 25. Brazil Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 26. Brazil Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 27. Brazil Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 28. Brazil Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 29. Argentina Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 30. Argentina Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 31. Argentina Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 32. Argentina Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 33. Rest of South America Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 34. Rest of South America Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 35. Rest of South America Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 36. Rest of South America Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 37. Asia Pacific Bovine-based Collagen for Biomedical Applications, by Country USD Million (2015-2020)
  • Table 38. Asia Pacific Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 39. Asia Pacific Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 40. Asia Pacific Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 41. Asia Pacific Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 42. China Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 43. China Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 44. China Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 45. China Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 46. Japan Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 47. Japan Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 48. Japan Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 49. Japan Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 50. India Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 51. India Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 52. India Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 53. India Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 54. South Korea Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 55. South Korea Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 56. South Korea Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 57. South Korea Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 58. Taiwan Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 59. Taiwan Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 60. Taiwan Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 61. Taiwan Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 62. Australia Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 63. Australia Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 64. Australia Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 65. Australia Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 70. Europe Bovine-based Collagen for Biomedical Applications, by Country USD Million (2015-2020)
  • Table 71. Europe Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 72. Europe Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 73. Europe Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 74. Europe Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 75. Germany Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 76. Germany Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 77. Germany Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 78. Germany Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 79. France Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 80. France Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 81. France Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 82. France Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 83. Italy Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 84. Italy Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 85. Italy Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 86. Italy Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 87. United Kingdom Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 88. United Kingdom Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 89. United Kingdom Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 90. United Kingdom Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 91. Netherlands Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 92. Netherlands Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 93. Netherlands Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 94. Netherlands Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 95. Rest of Europe Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 96. Rest of Europe Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 97. Rest of Europe Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 98. Rest of Europe Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 99. MEA Bovine-based Collagen for Biomedical Applications, by Country USD Million (2015-2020)
  • Table 100. MEA Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 101. MEA Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 102. MEA Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 103. MEA Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 104. Middle East Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 105. Middle East Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 106. Middle East Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 107. Middle East Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 108. Africa Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 109. Africa Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 110. Africa Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 111. Africa Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 112. North America Bovine-based Collagen for Biomedical Applications, by Country USD Million (2015-2020)
  • Table 113. North America Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 114. North America Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 115. North America Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 116. North America Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 117. United States Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 118. United States Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 119. United States Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 120. United States Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 121. Canada Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 122. Canada Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 123. Canada Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 124. Canada Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 125. Mexico Bovine-based Collagen for Biomedical Applications, by Application USD Million (2015-2020)
  • Table 126. Mexico Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2015-2020)
  • Table 127. Mexico Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2015-2020)
  • Table 128. Mexico Bovine-based Collagen for Biomedical Applications, by Source USD Million (2015-2020)
  • Table 129. Bovine-based Collagen for Biomedical Applications Sales: by Application(K Tons)
  • Table 130. Bovine-based Collagen for Biomedical Applications Sales Bone Graft Substitutes , by Region K Tons (2015-2020)
  • Table 131. Bovine-based Collagen for Biomedical Applications Sales Collagen-based Scaffolds , by Region K Tons (2015-2020)
  • Table 132. Bovine-based Collagen for Biomedical Applications Sales Hemostats , by Region K Tons (2015-2020)
  • Table 133. Bovine-based Collagen for Biomedical Applications Sales Skin Substitutes , by Region K Tons (2015-2020)
  • Table 134. Bovine-based Collagen for Biomedical Applications Sales Cartilage Repairs , by Region K Tons (2015-2020)
  • Table 135. Bovine-based Collagen for Biomedical Applications Sales Others , by Region K Tons (2015-2020)
  • Table 136. Bovine-based Collagen for Biomedical Applications Sales: by Major constituent(K Tons)
  • Table 137. Bovine-based Collagen for Biomedical Applications Sales Type-I Collagen , by Region K Tons (2015-2020)
  • Table 138. Bovine-based Collagen for Biomedical Applications Sales Type-III Collagen , by Region K Tons (2015-2020)
  • Table 139. Bovine-based Collagen for Biomedical Applications Sales: by Dosage forms(K Tons)
  • Table 140. Bovine-based Collagen for Biomedical Applications Sales Bovine Gelatin , by Region K Tons (2015-2020)
  • Table 141. Bovine-based Collagen for Biomedical Applications Sales Hydrolyzed Bovine Collagen , by Region K Tons (2015-2020)
  • Table 142. Bovine-based Collagen for Biomedical Applications Sales Others(Powder, Granule Agent ) , by Region K Tons (2015-2020)
  • Table 143. Bovine-based Collagen for Biomedical Applications Sales: by Source(K Tons)
  • Table 144. Bovine-based Collagen for Biomedical Applications Sales Cartilage , by Region K Tons (2015-2020)
  • Table 145. Bovine-based Collagen for Biomedical Applications Sales Bones , by Region K Tons (2015-2020)
  • Table 146. Bovine-based Collagen for Biomedical Applications Sales Hides of Cows , by Region K Tons (2015-2020)
  • Table 147. Bovine-based Collagen for Biomedical Applications Sales Others , by Region K Tons (2015-2020)
  • Table 148. South America Bovine-based Collagen for Biomedical Applications Sales, by Country K Tons (2015-2020)
  • Table 149. South America Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 150. South America Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 151. South America Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 152. South America Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 153. Brazil Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 154. Brazil Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 155. Brazil Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 156. Brazil Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 157. Argentina Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 158. Argentina Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 159. Argentina Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 160. Argentina Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 161. Rest of South America Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 162. Rest of South America Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 163. Rest of South America Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 164. Rest of South America Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 165. Asia Pacific Bovine-based Collagen for Biomedical Applications Sales, by Country K Tons (2015-2020)
  • Table 166. Asia Pacific Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 167. Asia Pacific Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 168. Asia Pacific Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 169. Asia Pacific Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 170. China Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 171. China Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 172. China Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 173. China Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 174. Japan Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 175. Japan Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 176. Japan Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 177. Japan Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 178. India Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 179. India Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 180. India Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 181. India Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 182. South Korea Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 183. South Korea Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 184. South Korea Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 185. South Korea Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 186. Taiwan Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 187. Taiwan Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 188. Taiwan Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 189. Taiwan Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 190. Australia Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 191. Australia Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 192. Australia Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 193. Australia Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 194. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 195. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 196. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 197. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 198. Europe Bovine-based Collagen for Biomedical Applications Sales, by Country K Tons (2015-2020)
  • Table 199. Europe Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 200. Europe Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 201. Europe Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 202. Europe Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 203. Germany Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 204. Germany Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 205. Germany Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 206. Germany Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 207. France Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 208. France Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 209. France Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 210. France Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 211. Italy Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 212. Italy Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 213. Italy Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 214. Italy Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 215. United Kingdom Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 216. United Kingdom Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 217. United Kingdom Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 218. United Kingdom Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 219. Netherlands Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 220. Netherlands Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 221. Netherlands Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 222. Netherlands Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 223. Rest of Europe Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 224. Rest of Europe Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 225. Rest of Europe Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 226. Rest of Europe Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 227. MEA Bovine-based Collagen for Biomedical Applications Sales, by Country K Tons (2015-2020)
  • Table 228. MEA Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 229. MEA Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 230. MEA Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 231. MEA Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 232. Middle East Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 233. Middle East Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 234. Middle East Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 235. Middle East Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 236. Africa Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 237. Africa Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 238. Africa Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 239. Africa Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 240. North America Bovine-based Collagen for Biomedical Applications Sales, by Country K Tons (2015-2020)
  • Table 241. North America Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 242. North America Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 243. North America Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 244. North America Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 245. United States Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 246. United States Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 247. United States Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 248. United States Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 249. Canada Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 250. Canada Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 251. Canada Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 252. Canada Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 253. Mexico Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2015-2020)
  • Table 254. Mexico Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2015-2020)
  • Table 255. Mexico Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2015-2020)
  • Table 256. Mexico Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2015-2020)
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Bovine-based Collagen for Biomedical Applications: by Application(USD Million)
  • Table 268. Bovine-based Collagen for Biomedical Applications Bone Graft Substitutes , by Region USD Million (2021-2026)
  • Table 269. Bovine-based Collagen for Biomedical Applications Collagen-based Scaffolds , by Region USD Million (2021-2026)
  • Table 270. Bovine-based Collagen for Biomedical Applications Hemostats , by Region USD Million (2021-2026)
  • Table 271. Bovine-based Collagen for Biomedical Applications Skin Substitutes , by Region USD Million (2021-2026)
  • Table 272. Bovine-based Collagen for Biomedical Applications Cartilage Repairs , by Region USD Million (2021-2026)
  • Table 273. Bovine-based Collagen for Biomedical Applications Others , by Region USD Million (2021-2026)
  • Table 274. Bovine-based Collagen for Biomedical Applications: by Major constituent(USD Million)
  • Table 275. Bovine-based Collagen for Biomedical Applications Type-I Collagen , by Region USD Million (2021-2026)
  • Table 276. Bovine-based Collagen for Biomedical Applications Type-III Collagen , by Region USD Million (2021-2026)
  • Table 277. Bovine-based Collagen for Biomedical Applications: by Dosage forms(USD Million)
  • Table 278. Bovine-based Collagen for Biomedical Applications Bovine Gelatin , by Region USD Million (2021-2026)
  • Table 279. Bovine-based Collagen for Biomedical Applications Hydrolyzed Bovine Collagen , by Region USD Million (2021-2026)
  • Table 280. Bovine-based Collagen for Biomedical Applications Others(Powder, Granule Agent ) , by Region USD Million (2021-2026)
  • Table 281. Bovine-based Collagen for Biomedical Applications: by Source(USD Million)
  • Table 282. Bovine-based Collagen for Biomedical Applications Cartilage , by Region USD Million (2021-2026)
  • Table 283. Bovine-based Collagen for Biomedical Applications Bones , by Region USD Million (2021-2026)
  • Table 284. Bovine-based Collagen for Biomedical Applications Hides of Cows , by Region USD Million (2021-2026)
  • Table 285. Bovine-based Collagen for Biomedical Applications Others , by Region USD Million (2021-2026)
  • Table 286. South America Bovine-based Collagen for Biomedical Applications, by Country USD Million (2021-2026)
  • Table 287. South America Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 288. South America Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 289. South America Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 290. South America Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 291. Brazil Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 292. Brazil Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 293. Brazil Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 294. Brazil Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 295. Argentina Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 296. Argentina Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 297. Argentina Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 298. Argentina Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 299. Rest of South America Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 300. Rest of South America Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 301. Rest of South America Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 302. Rest of South America Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 303. Asia Pacific Bovine-based Collagen for Biomedical Applications, by Country USD Million (2021-2026)
  • Table 304. Asia Pacific Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 305. Asia Pacific Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 306. Asia Pacific Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 307. Asia Pacific Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 308. China Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 309. China Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 310. China Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 311. China Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 312. Japan Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 313. Japan Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 314. Japan Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 315. Japan Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 316. India Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 317. India Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 318. India Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 319. India Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 320. South Korea Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 321. South Korea Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 322. South Korea Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 323. South Korea Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 324. Taiwan Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 325. Taiwan Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 326. Taiwan Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 327. Taiwan Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 328. Australia Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 329. Australia Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 330. Australia Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 331. Australia Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 332. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 333. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 334. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 335. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 336. Europe Bovine-based Collagen for Biomedical Applications, by Country USD Million (2021-2026)
  • Table 337. Europe Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 338. Europe Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 339. Europe Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 340. Europe Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 341. Germany Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 342. Germany Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 343. Germany Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 344. Germany Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 345. France Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 346. France Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 347. France Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 348. France Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 349. Italy Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 350. Italy Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 351. Italy Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 352. Italy Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 353. United Kingdom Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 354. United Kingdom Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 355. United Kingdom Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 356. United Kingdom Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 357. Netherlands Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 358. Netherlands Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 359. Netherlands Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 360. Netherlands Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 361. Rest of Europe Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 362. Rest of Europe Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 363. Rest of Europe Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 364. Rest of Europe Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 365. MEA Bovine-based Collagen for Biomedical Applications, by Country USD Million (2021-2026)
  • Table 366. MEA Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 367. MEA Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 368. MEA Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 369. MEA Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 370. Middle East Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 371. Middle East Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 372. Middle East Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 373. Middle East Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 374. Africa Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 375. Africa Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 376. Africa Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 377. Africa Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 378. North America Bovine-based Collagen for Biomedical Applications, by Country USD Million (2021-2026)
  • Table 379. North America Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 380. North America Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 381. North America Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 382. North America Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 383. United States Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 384. United States Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 385. United States Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 386. United States Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 387. Canada Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 388. Canada Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 389. Canada Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 390. Canada Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 391. Mexico Bovine-based Collagen for Biomedical Applications, by Application USD Million (2021-2026)
  • Table 392. Mexico Bovine-based Collagen for Biomedical Applications, by Major constituent USD Million (2021-2026)
  • Table 393. Mexico Bovine-based Collagen for Biomedical Applications, by Dosage forms USD Million (2021-2026)
  • Table 394. Mexico Bovine-based Collagen for Biomedical Applications, by Source USD Million (2021-2026)
  • Table 395. Bovine-based Collagen for Biomedical Applications Sales: by Application(K Tons)
  • Table 396. Bovine-based Collagen for Biomedical Applications Sales Bone Graft Substitutes , by Region K Tons (2021-2026)
  • Table 397. Bovine-based Collagen for Biomedical Applications Sales Collagen-based Scaffolds , by Region K Tons (2021-2026)
  • Table 398. Bovine-based Collagen for Biomedical Applications Sales Hemostats , by Region K Tons (2021-2026)
  • Table 399. Bovine-based Collagen for Biomedical Applications Sales Skin Substitutes , by Region K Tons (2021-2026)
  • Table 400. Bovine-based Collagen for Biomedical Applications Sales Cartilage Repairs , by Region K Tons (2021-2026)
  • Table 401. Bovine-based Collagen for Biomedical Applications Sales Others , by Region K Tons (2021-2026)
  • Table 402. Bovine-based Collagen for Biomedical Applications Sales: by Major constituent(K Tons)
  • Table 403. Bovine-based Collagen for Biomedical Applications Sales Type-I Collagen , by Region K Tons (2021-2026)
  • Table 404. Bovine-based Collagen for Biomedical Applications Sales Type-III Collagen , by Region K Tons (2021-2026)
  • Table 405. Bovine-based Collagen for Biomedical Applications Sales: by Dosage forms(K Tons)
  • Table 406. Bovine-based Collagen for Biomedical Applications Sales Bovine Gelatin , by Region K Tons (2021-2026)
  • Table 407. Bovine-based Collagen for Biomedical Applications Sales Hydrolyzed Bovine Collagen , by Region K Tons (2021-2026)
  • Table 408. Bovine-based Collagen for Biomedical Applications Sales Others(Powder, Granule Agent ) , by Region K Tons (2021-2026)
  • Table 409. Bovine-based Collagen for Biomedical Applications Sales: by Source(K Tons)
  • Table 410. Bovine-based Collagen for Biomedical Applications Sales Cartilage , by Region K Tons (2021-2026)
  • Table 411. Bovine-based Collagen for Biomedical Applications Sales Bones , by Region K Tons (2021-2026)
  • Table 412. Bovine-based Collagen for Biomedical Applications Sales Hides of Cows , by Region K Tons (2021-2026)
  • Table 413. Bovine-based Collagen for Biomedical Applications Sales Others , by Region K Tons (2021-2026)
  • Table 414. South America Bovine-based Collagen for Biomedical Applications Sales, by Country K Tons (2021-2026)
  • Table 415. South America Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 416. South America Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 417. South America Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 418. South America Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 419. Brazil Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 420. Brazil Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 421. Brazil Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 422. Brazil Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 423. Argentina Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 424. Argentina Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 425. Argentina Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 426. Argentina Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 427. Rest of South America Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 428. Rest of South America Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 429. Rest of South America Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 430. Rest of South America Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 431. Asia Pacific Bovine-based Collagen for Biomedical Applications Sales, by Country K Tons (2021-2026)
  • Table 432. Asia Pacific Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 433. Asia Pacific Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 434. Asia Pacific Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 435. Asia Pacific Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 436. China Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 437. China Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 438. China Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 439. China Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 440. Japan Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 441. Japan Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 442. Japan Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 443. Japan Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 444. India Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 445. India Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 446. India Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 447. India Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 448. South Korea Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 449. South Korea Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 450. South Korea Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 451. South Korea Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 452. Taiwan Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 453. Taiwan Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 454. Taiwan Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 455. Taiwan Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 456. Australia Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 457. Australia Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 458. Australia Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 459. Australia Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 460. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 461. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 462. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 463. Rest of Asia-Pacific Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 464. Europe Bovine-based Collagen for Biomedical Applications Sales, by Country K Tons (2021-2026)
  • Table 465. Europe Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 466. Europe Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 467. Europe Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 468. Europe Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 469. Germany Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 470. Germany Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 471. Germany Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 472. Germany Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 473. France Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 474. France Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 475. France Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 476. France Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 477. Italy Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 478. Italy Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 479. Italy Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 480. Italy Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 481. United Kingdom Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 482. United Kingdom Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 483. United Kingdom Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 484. United Kingdom Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 485. Netherlands Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 486. Netherlands Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 487. Netherlands Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 488. Netherlands Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 489. Rest of Europe Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 490. Rest of Europe Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 491. Rest of Europe Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 492. Rest of Europe Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 493. MEA Bovine-based Collagen for Biomedical Applications Sales, by Country K Tons (2021-2026)
  • Table 494. MEA Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 495. MEA Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 496. MEA Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 497. MEA Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 498. Middle East Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 499. Middle East Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 500. Middle East Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 501. Middle East Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 502. Africa Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 503. Africa Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 504. Africa Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 505. Africa Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 506. North America Bovine-based Collagen for Biomedical Applications Sales, by Country K Tons (2021-2026)
  • Table 507. North America Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 508. North America Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 509. North America Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 510. North America Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 511. United States Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 512. United States Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 513. United States Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 514. United States Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 515. Canada Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 516. Canada Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 517. Canada Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 518. Canada Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 519. Mexico Bovine-based Collagen for Biomedical Applications Sales, by Application K Tons (2021-2026)
  • Table 520. Mexico Bovine-based Collagen for Biomedical Applications Sales, by Major constituent K Tons (2021-2026)
  • Table 521. Mexico Bovine-based Collagen for Biomedical Applications Sales, by Dosage forms K Tons (2021-2026)
  • Table 522. Mexico Bovine-based Collagen for Biomedical Applications Sales, by Source K Tons (2021-2026)
  • Table 523. Research Programs/Design for This Report
  • Table 524. Key Data Information from Secondary Sources
  • Table 525. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bovine-based Collagen for Biomedical Applications: by Application USD Million (2015-2020)
  • Figure 5. Global Bovine-based Collagen for Biomedical Applications: by Major constituent USD Million (2015-2020)
  • Figure 6. Global Bovine-based Collagen for Biomedical Applications: by Dosage forms USD Million (2015-2020)
  • Figure 7. Global Bovine-based Collagen for Biomedical Applications: by Source USD Million (2015-2020)
  • Figure 8. South America Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 9. Asia Pacific Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 10. Europe Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 11. MEA Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 12. North America Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 13. Global Bovine-based Collagen for Biomedical Applications: by Application K Tons (2015-2020)
  • Figure 14. Global Bovine-based Collagen for Biomedical Applications: by Major constituent K Tons (2015-2020)
  • Figure 15. Global Bovine-based Collagen for Biomedical Applications: by Dosage forms K Tons (2015-2020)
  • Figure 16. Global Bovine-based Collagen for Biomedical Applications: by Source K Tons (2015-2020)
  • Figure 17. South America Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 18. Asia Pacific Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 19. Europe Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 20. MEA Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 21. North America Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 22. Global Bovine-based Collagen for Biomedical Applications share by Players 2020 (%)
  • Figure 23. Global Bovine-based Collagen for Biomedical Applications share by Players (Top 3) 2020(%)
  • Figure 24. Global Bovine-based Collagen for Biomedical Applications share by Players (Top 5) 2020(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. BBI Solutions (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. BBI Solutions (United Kingdom) Revenue: by Geography 2020
  • Figure 28. Symatese (France) Revenue, Net Income and Gross profit
  • Figure 29. Symatese (France) Revenue: by Geography 2020
  • Figure 30. Gurnet Point Capital(United States) Revenue, Net Income and Gross profit
  • Figure 31. Gurnet Point Capital(United States) Revenue: by Geography 2020
  • Figure 32. Collagen Solutions LLP(United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. Collagen Solutions LLP(United Kingdom) Revenue: by Geography 2020
  • Figure 34. Botiss biomaterials GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Botiss biomaterials GmbH (Germany) Revenue: by Geography 2020
  • Figure 36. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 37. Medtronic (Ireland) Revenue: by Geography 2020
  • Figure 38. Taxus Cardium (United States) Revenue, Net Income and Gross profit
  • Figure 39. Taxus Cardium (United States) Revenue: by Geography 2020
  • Figure 40. KYERON (India) Revenue, Net Income and Gross profit
  • Figure 41. KYERON (India) Revenue: by Geography 2020
  • Figure 42. Collagen Matrix, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 43. Collagen Matrix, Inc (United States) Revenue: by Geography 2020
  • Figure 44. FOODMATE CO., LTD. (China) Revenue, Net Income and Gross profit
  • Figure 45. FOODMATE CO., LTD. (China) Revenue: by Geography 2020
  • Figure 46. Global Bovine-based Collagen for Biomedical Applications: by Application USD Million (2021-2026)
  • Figure 47. Global Bovine-based Collagen for Biomedical Applications: by Major constituent USD Million (2021-2026)
  • Figure 48. Global Bovine-based Collagen for Biomedical Applications: by Dosage forms USD Million (2021-2026)
  • Figure 49. Global Bovine-based Collagen for Biomedical Applications: by Source USD Million (2021-2026)
  • Figure 50. South America Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 51. Asia Pacific Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 52. Europe Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 53. MEA Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 54. North America Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 55. Global Bovine-based Collagen for Biomedical Applications: by Application K Tons (2021-2026)
  • Figure 56. Global Bovine-based Collagen for Biomedical Applications: by Major constituent K Tons (2021-2026)
  • Figure 57. Global Bovine-based Collagen for Biomedical Applications: by Dosage forms K Tons (2021-2026)
  • Figure 58. Global Bovine-based Collagen for Biomedical Applications: by Source K Tons (2021-2026)
  • Figure 59. South America Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 60. Asia Pacific Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 61. Europe Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 62. MEA Bovine-based Collagen for Biomedical Applications Share (%), by Country
  • Figure 63. North America Bovine-based Collagen for Biomedical Applications Share (%), by Country
List of companies from research coverage that are profiled in the study
  • BBI Solutions (United Kingdom)
  • Symatese (France)
  • Gurnet Point Capital(United States)
  • Collagen Solutions LLP(United Kingdom)
  • Botiss biomaterials GmbH (Germany)
  • Medtronic (Ireland)
  • Taxus Cardium (United States)
  • KYERON (India)
  • Collagen Matrix, Inc (United States)
  • FOODMATE CO., LTD. (China)
Additional players considered in the study are as follows:
Weishardt (France) , Nitta Gelatin Inc.(Japan) , LAPI GELATINE S.p.a.(Italy)
Select User Access Type

Key Highlights of Report


Apr 2021 234 Pages 62 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Bovine-based Collagen for Biomedical Applications Market Quantitative research analysis
Global Bovine-based Collagen for Biomedical Applications Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Bovine-based Collagen for Biomedical Applications market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Bovine-based Collagen for Biomedical Applications market are BBI Solutions (United Kingdom), Symatese (France), Gurnet Point Capital(United States), Collagen Solutions LLP(United Kingdom), Botiss biomaterials GmbH (Germany), Medtronic (Ireland), Taxus Cardium (United States), KYERON (India), Collagen Matrix, Inc (United States) and FOODMATE CO., LTD. (China), to name a few.
In this highly competitive & fast evolving Bovine-based Collagen for Biomedical Applications industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Bovine-based Collagen for Biomedical Applications Market Report?

Have a Query? Click Here

Other Related Reports

Transdermal Drug Patches Comprehensive Study by Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patc...
$ 3750
Meropenem Comprehensive Study by Application (Skin and Skin Structure Infection, Intra-abdominal infection, Meningitis, Nosocomial Infection, Others), End Users (Adult, Pediatric), Distribution Chann...
$ 3450
Cardiac Troponin Comprehensive Study by Type (CTn T, CTn I, TnC), Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others Applications), End User (Laboratory Tes...
$ 3350
Branded Generics Comprehensive Study by Type (Value Added Branded Generics, Trade (Brand) Named Generics), Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, Others)...
$ 3650
Insulin Glargine Comprehensive Study by Application (Type 1 Diabetes (T1D), Type 2 Diabetes (T2D)), Forms (Liquid, Tablet, Syrup, Cream, Gel), Side Effect (Rash, Hives, Itching, Wheezing), Distribut...
$ 3800
Topical Pain Relief Comprehensive Study by Type (Prescription Pain Relief Products, Over-the-counter (OTC) Pain Relief Products), Application (Pets, Mammals, Farm Animals), Distribution Channel (Phar...
$ 3650